Effects of Sulfate-Rich Mineral Water on Functional Constipation: A Double-Blind, Randomized, Placebo-Controlled Study

被引:19
|
作者
Naumann, Johannes [1 ]
Sadaghiani, Catharina [1 ]
Alt, Felix [2 ]
Huber, Roman [3 ]
机构
[1] Univ Med Ctr Freiburg, Interdisciplinary Ctr Treatment & Res Balneol, Fac Med, Inst Environm Hlth Sci & Hosp Infect Control, Breisacher Str 115b, D-79106 Freiburg, Germany
[2] Analyze & Realize GmbH, Clin Res, Berlin, Germany
[3] Univ Med Ctr Freiburg, Fac Med, Ctr Complementary Med, Inst Environm Hlth Sci & Hosp Infect Control, Freiburg, Germany
来源
FORSCHENDE KOMPLEMENTARMEDIZIN | 2016年 / 23卷 / 06期
关键词
Functional constipation; Bowel movements; Mineral water; Sulfate; Magnesium; CARBONATED WATER; BICARBONATE; MAGNESIUM; HEALTH; VALIDATION; CALCIUM; FIBER; RISK;
D O I
10.1159/000449436
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Background: Magnesium sulfate has a long tradition as a laxative. It osmotically prevents water absorption in the large bowel and thus leads to an acceleration of the intestinal transit and better stool consistency. We wanted to investigate the efficacy of a carbonated calcium/magnesium sulfate-rich natural mineral water in subjects with functional constipation (FC). Patients and Methods: In this double-blind, randomized, placebo-controlled study, subjects with FC (Rome III criteria) received 1 l/day (4 x 250 ml) of mineral water (Ensinger Schiller Quelle) or carbonated tap water (placebo) for 6 weeks. The primary endpoint was the change in the frequency of bowel movements per week between baseline and visit 4 (after 6 weeks). The prespecified main secondary endpoint was the change in the frequency of bowel movements per week between baseline and visit 3 (after 3 weeks). Results: Efficacy was analyzed in 100 subjects (intention-to-treat). After 6 weeks of treatment there was no statistical difference between the groups (p = 0.163). However, statistical significance was reached after 3 weeks, with an increase in the frequency of bowel movements per week of 2.02 +/- 2.22 for the mineral water group compared to 0.88 +/- 1.67 for the placebo group (p = 0.005). Conclusions: A 3-week treatment with 1 l/day of the sulfate-rich mineral water improved the frequency of bowel movements in subjects with FC compared with tap water; however, the difference was no longer significant after 6 weeks. Further evaluation in rigorously designed clinical studies will be necessary to validate the impact of sulfate-rich natural mineral water on FC. (C) 2016 S. Karger GmbH, Freiburg
引用
收藏
页码:356 / 363
页数:8
相关论文
共 50 条
  • [21] Effects of bendroflumethiazide on bone mineral density; results from the BONATHIAD randomized double-blind placebo-controlled cohort study
    Emmanuel, Thomas
    Kruse, Christian
    Leere, Julius Simoni
    Poulsen, Trine Holmgaard
    Vestergaard, Peter
    BONE REPORTS, 2020, 13
  • [22] A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PILOT TRIAL OF INTRAVENOUS MAGNESIUM-SULFATE IN ACUTE STROKE
    MUIR, KW
    LEES, KR
    STROKE, 1995, 26 (07) : 1183 - 1188
  • [23] Design of a phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of prucalopride in pediatric patients with functional constipation
    Cuffari, Carmen
    Spalding, William
    Achenbach, Heinrich
    Thakur, Manoj
    Gabriel, Andre
    CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2023, 33
  • [24] Bacillus coagulans Unique IS2 in Constipation: A Double-Blind, Placebo-Controlled Study
    Ratna Sudha Madempudi
    Jayanthi Neelamraju
    Jayesh J. Ahire
    Sandeep K. Gupta
    Vineet K. Shukla
    Probiotics and Antimicrobial Proteins, 2020, 12 : 335 - 342
  • [25] Magnesium in the prophylaxis of migraine - A double-blind, placebo-controlled study
    Pfaffenrath, V
    Wessely, P
    Meyer, C
    Isler, HR
    Evers, S
    Grotemeyer, KH
    Taneri, Z
    Soyka, D
    Gobel, H
    Fischer, M
    CEPHALALGIA, 1996, 16 (06) : 436 - 440
  • [26] Antiplatelet effects of citalopram in patients with ischaemic stroke: A randomized, placebo-controlled, double-blind study
    Kraglund, Kristian Lundsgaard
    Mortensen, Janne Kaergaard
    Johnsen, Soren Paaske
    Andersen, Grethe
    Grove, Erik Lerkevang
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [27] Effects of the PREMEN-CALM® in the Management of the Premenstrual Syndrome: A Randomized, Double-Blind, Placebo-Controlled Pilot Study
    Herrera, Andrea
    Al Adib, Miriam
    Rodriguez, Ana Beatriz
    Carrasco, Cristina
    JOURNAL OF DIETARY SUPPLEMENTS, 2024, 21 (04) : 495 - 511
  • [28] Efficacy and safety of lubiprostone for the treatment of functional constipation in Chinese adult patients: A multicenter, randomized, double-blind, placebo-controlled trial
    Xiao, Ying Lian
    Dai, Ning
    He, Shui Xiang
    Tian, De An
    Liu, Si De
    Tian, Zi Bin
    Wang, Xiao Yan
    Li, Yan Qing
    Hou, Xiao Hua
    Fang, Xiu Cai
    Wen, Zhi Li
    Zeng, Wei Zheng
    Xu, Hong
    Sun, Ming Jun
    Liu, Yu Lan
    Wu, Yong Dong
    Shen, Xi Zhong
    Liu, Xiao Wei
    Liu, De Liang
    Chen, Min Hu
    JOURNAL OF DIGESTIVE DISEASES, 2021, 22 (11) : 622 - 629
  • [29] Gastrointestinal Complications of Ferrous Sulfate in Pregnant Women: A Randomized Double-Blind Placebo-Controlled Trial
    Jafarbegloo, Esmat
    Tehran, Hoda Ahmari
    Tehrani, Tahmineh Dadkhah
    IRANIAN RED CRESCENT MEDICAL JOURNAL, 2015, 17 (08)
  • [30] Efficacy of microbial cell preparation in improving chronic constipation: A randomized, double-blind, placebo-controlled trial
    Jayasimhan, Sanmugapriya
    Yap, Ning-Yi
    Roest, Yvonne
    Rajandram, Retnagowri
    Chin, Kin-Fah
    CLINICAL NUTRITION, 2013, 32 (06) : 928 - 934